An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People
Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long‐ter...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 69; no. 1; pp. 19 - 33 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health, Inc
01.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long‐term serial samples from 20 HCC patients with HBV infection. Complete sequence analyses revealed that all isolates were genotype F1b. In the HCC patients, T1938C and A2051C mutations in the core region had accumulated significantly with A1762T/G1764A mutations in the basal core promoter (BCP) region and G1896A mutation in the precore (PC) region. Several HBV clones containing the core mutations were examined for their replication efficiency and core stability in vitro. Clones containing the A2051C mutation replicated more efficiently than the wild type in association with enhanced stability of core protein dimerization. In chimeric mice with human hepatocytes carrying BCP/PC/2051 mutant but not with wild‐type virus, liver fibrosis was induced in association with high levels of serum HBV DNA and hepatitis B surface antigen. Interestingly, microarray analysis and validation study showed that five genes associated with cell proliferation or carcinogenesis, v‐myc avian myelocytomatosis viral oncogene homolog, Grb2‐associated binding protein 2, bradykinin receptor B2, follistatin, and mitogen‐activated protein kinase kinase kinase 8, were significantly up‐regulated in human hepatocytes infected with genotype F1b, particularly the BCP/PC/2051 mutant, compared with other genotypes. Conclusion: We have identified an association between Alaska‐specific core mutations and HCC development in AN people infected with genotype F1b; accumulation of these core mutations during the course of chronic infection with genotype F1b would contribute to HCC development in AN people earlier in life. |
---|---|
AbstractList | Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long-term serial samples from 20 HCC patients with HBV infection. Complete sequence analyses revealed that all isolates were genotype F1b. In the HCC patients, T1938C and A2051C mutations in the core region had accumulated significantly with A1762T/G1764A mutations in the basal core promoter (BCP) region and G1896A mutation in the precore (PC) region. Several HBV clones containing the core mutations were examined for their replication efficiency and core stability in vitro. Clones containing the A2051C mutation replicated more efficiently than the wild type in association with enhanced stability of core protein dimerization. In chimeric mice with human hepatocytes carrying BCP/PC/2051 mutant but not with wild-type virus, liver fibrosis was induced in association with high levels of serum HBV DNA and hepatitis B surface antigen. Interestingly, microarray analysis and validation study showed that five genes associated with cell proliferation or carcinogenesis, v-myc avian myelocytomatosis viral oncogene homolog, Grb2-associated binding protein 2, bradykinin receptor B2, follistatin, and mitogen-activated protein kinase kinase kinase 8, were significantly up-regulated in human hepatocytes infected with genotype F1b, particularly the BCP/PC/2051 mutant, compared with other genotypes. Conclusion: We have identified an association between Alaska-specific core mutations and HCC development in AN people infected with genotype F1b; accumulation of these core mutations during the course of chronic infection with genotype F1b would contribute to HCC development in AN people earlier in life.Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long-term serial samples from 20 HCC patients with HBV infection. Complete sequence analyses revealed that all isolates were genotype F1b. In the HCC patients, T1938C and A2051C mutations in the core region had accumulated significantly with A1762T/G1764A mutations in the basal core promoter (BCP) region and G1896A mutation in the precore (PC) region. Several HBV clones containing the core mutations were examined for their replication efficiency and core stability in vitro. Clones containing the A2051C mutation replicated more efficiently than the wild type in association with enhanced stability of core protein dimerization. In chimeric mice with human hepatocytes carrying BCP/PC/2051 mutant but not with wild-type virus, liver fibrosis was induced in association with high levels of serum HBV DNA and hepatitis B surface antigen. Interestingly, microarray analysis and validation study showed that five genes associated with cell proliferation or carcinogenesis, v-myc avian myelocytomatosis viral oncogene homolog, Grb2-associated binding protein 2, bradykinin receptor B2, follistatin, and mitogen-activated protein kinase kinase kinase 8, were significantly up-regulated in human hepatocytes infected with genotype F1b, particularly the BCP/PC/2051 mutant, compared with other genotypes. Conclusion: We have identified an association between Alaska-specific core mutations and HCC development in AN people infected with genotype F1b; accumulation of these core mutations during the course of chronic infection with genotype F1b would contribute to HCC development in AN people earlier in life. Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the mechanisms by which genotype F1b causes HCC are unclear. Here, we analyzed the clinical and virological significance of genotype F1b in long‐term serial samples from 20 HCC patients with HBV infection. Complete sequence analyses revealed that all isolates were genotype F1b. In the HCC patients, T1938C and A2051C mutations in the core region had accumulated significantly with A1762T/G1764A mutations in the basal core promoter (BCP) region and G1896A mutation in the precore (PC) region. Several HBV clones containing the core mutations were examined for their replication efficiency and core stability in vitro. Clones containing the A2051C mutation replicated more efficiently than the wild type in association with enhanced stability of core protein dimerization. In chimeric mice with human hepatocytes carrying BCP/PC/2051 mutant but not with wild‐type virus, liver fibrosis was induced in association with high levels of serum HBV DNA and hepatitis B surface antigen. Interestingly, microarray analysis and validation study showed that five genes associated with cell proliferation or carcinogenesis, v‐myc avian myelocytomatosis viral oncogene homolog, Grb2‐associated binding protein 2, bradykinin receptor B2, follistatin, and mitogen‐activated protein kinase kinase kinase 8, were significantly up‐regulated in human hepatocytes infected with genotype F1b, particularly the BCP/PC/2051 mutant, compared with other genotypes. Conclusion: We have identified an association between Alaska‐specific core mutations and HCC development in AN people infected with genotype F1b; accumulation of these core mutations during the course of chronic infection with genotype F1b would contribute to HCC development in AN people earlier in life. |
Author | Takahashi, Satoru Hayashi, Sanae Ogawa, Kenji McMahon, Brian J. Simons, Brenna C. Mizokami, Masashi Ikeo, Kazuho Isogawa, Masanori Matsui, Takeshi Homan, Chriss Murakami, Shuko Tanaka, Yasuhito Khan, Anis Kawashima, Keigo |
Author_xml | – sequence: 1 givenname: Sanae surname: Hayashi fullname: Hayashi, Sanae organization: Nagoya City University Graduate School of Medical Science – sequence: 2 givenname: Anis surname: Khan fullname: Khan, Anis organization: Nagoya City University Graduate School of Medical Science – sequence: 3 givenname: Brenna C. surname: Simons fullname: Simons, Brenna C. organization: Alaska Native Tribal Health Consortium – sequence: 4 givenname: Chriss surname: Homan fullname: Homan, Chriss organization: Alaska Native Tribal Health Consortium – sequence: 5 givenname: Takeshi surname: Matsui fullname: Matsui, Takeshi organization: Teine Keijinkai Hospital – sequence: 6 givenname: Kenji surname: Ogawa fullname: Ogawa, Kenji organization: Chemical Genetics Laboratory – sequence: 7 givenname: Keigo surname: Kawashima fullname: Kawashima, Keigo organization: Nagoya City University Graduate School of Medical Science – sequence: 8 givenname: Shuko surname: Murakami fullname: Murakami, Shuko organization: Nagoya City University Graduate School of Medical Science – sequence: 9 givenname: Satoru surname: Takahashi fullname: Takahashi, Satoru organization: Nagoya City University Graduate School of Medical Sciences – sequence: 10 givenname: Masanori surname: Isogawa fullname: Isogawa, Masanori organization: Nagoya City University Graduate School of Medical Science – sequence: 11 givenname: Kazuho surname: Ikeo fullname: Ikeo, Kazuho organization: National Institute of Genetics – sequence: 12 givenname: Masashi surname: Mizokami fullname: Mizokami, Masashi organization: National Center for Global Health and Medicine – sequence: 13 givenname: Brian J. surname: McMahon fullname: McMahon, Brian J. organization: Alaska Native Tribal Health Consortium – sequence: 14 givenname: Yasuhito surname: Tanaka fullname: Tanaka, Yasuhito email: ytanaka@med.nagoya-cu.ac.jp organization: Nagoya City University Graduate School of Medical Science |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29893492$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUFP3DAQha0KVBbaQ_9AZakXegh4bCcbH5cVsEi05VC4Wl5noppm7dROivbQ_14vAQ5I7Wk0o-89zcw7JHs-eCTkA7ATYIyf_sD-RDAAeENmUPJ5IUTJ9siM8TkrFAh1QA5TumeMKcnrt-SAq1oJqfiM_Fl4ukgpWGcGFzw9w-EB0dNliEi_jMPjNFHn6Qr73Awu0TN65-KY6CX6MGx7pBewpsY3ExIsdt3YmUiXJlrnw8bs5IvOpJ_G06_Z5DfSGwx9h-_Ifmu6hO-f6hG5vTj_vlwV198ur5aL68JKUFCseSUbMI2wgpVG1oBMAK_XKFUNjKPk87YpDYhKtq2wlufToBWmqkXb8Dw6IseTbx_DrxHToDcu7fY0HsOYNGdllsiqEhn99Aq9D2P0eTvNoZKSVwAqUx-fqHG9wUb30W1M3Ornx2bg8wTYGFKK2L4gwPQuNJ1D04-hZfb0FWvd9PghGtf9T_HgOtz-21qvzm8mxV851qZV |
CitedBy_id | crossref_primary_10_1016_j_clinre_2020_04_018 crossref_primary_10_3138_canlivj_2024_0014 crossref_primary_10_1007_s00535_023_02070_y crossref_primary_10_3389_fviro_2022_926831 crossref_primary_10_1002_hep_32065 crossref_primary_10_3892_ol_2019_10291 crossref_primary_10_1111_hepr_13398 crossref_primary_10_1016_j_antiviral_2024_106005 crossref_primary_10_3390_ijms222011051 crossref_primary_10_3390_cancers15020533 crossref_primary_10_1093_carcin_bgaa127 crossref_primary_10_1016_j_virs_2024_03_003 crossref_primary_10_1016_j_virusres_2025_199550 crossref_primary_10_1002_hep_30231 crossref_primary_10_1002_hep4_1460 crossref_primary_10_3390_v13101920 crossref_primary_10_3390_v16020245 crossref_primary_10_3389_fmicb_2022_946703 crossref_primary_10_1155_2024_8823341 crossref_primary_10_1016_j_jiph_2021_01_013 crossref_primary_10_1016_j_clinre_2018_10_019 crossref_primary_10_18632_oncotarget_27890 crossref_primary_10_3389_fonc_2022_836517 crossref_primary_10_1002_cld_1178 crossref_primary_10_3389_fnut_2024_1379364 |
Cites_doi | 10.1038/onc.2010.143 10.1007/s12072-008-9112-z 10.1053/jhep.2001.27221 10.1007/s13277-016-5019-9 10.1111/j.1872-034X.2007.00262.x 10.1053/j.gastro.2008.10.048 10.1074/jbc.M111.257378 10.1038/sj.onc.1206401 10.1086/509898 10.4161/cbt.3.12.1392 10.1016/j.canlet.2009.07.013 10.1128/JVI.00462-09 10.1016/j.ympev.2011.01.010 10.1159/000335472 10.1086/509894 10.3851/IMP2599 10.1002/hep.20365 10.1158/1541-7786.MCR-12-0352 10.1016/S0065-3527(04)63001-6 10.1074/jbc.M113.501122 10.1038/ajg.2008.57 10.1038/351317a0 10.1016/j.jhep.2015.03.020 10.1016/S0140-6736(14)61682-2 10.1055/s-2007-1007117 10.1016/j.semcancer.2010.10.011 10.1016/S0016-5085(00)70261-7 10.1016/S0016-5085(00)70370-2 10.1074/jbc.M501564200 10.1159/000360947 10.1093/oxfordjournals.aje.a116888 10.1111/liv.13129 10.18632/oncotarget.7123 10.1084/jem.188.2.341 10.1016/S0140-6736(15)61412-X 10.1016/j.cgh.2013.09.005 10.1007/978-3-7091-5633-9_12 10.1093/jnci/djn243 10.1002/hep.21345 10.1053/j.gastro.2014.06.043 10.1001/archinte.1990.00390170087019 10.1016/j.virusres.2007.12.005 10.1128/JVI.00577-13 |
ContentType | Journal Article |
Copyright | 2018 by the American Association for the Study of Liver Diseases. 2019 by the American Association for the Study of Liver Diseases. |
Copyright_xml | – notice: 2018 by the American Association for the Study of Liver Diseases. – notice: 2019 by the American Association for the Study of Liver Diseases. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/hep.30111 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 33 |
ExternalDocumentID | 29893492 10_1002_hep_30111 HEP30111 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Alaska |
GeographicLocations_xml | – name: Alaska |
GrantInformation_xml | – fundername: Japan Agency for Medical Research and Development funderid: 17fk0310101h0001; JP16fk0310512h0005; JP18fk0310101h0002 – fundername: Ministry of Health, Labor, and Welfare of Japan funderid: H26‐Bsou‐kanen‐ippan‐013 – fundername: Gilead Sciences funderid: IN‐US‐334‐2090 – fundername: Ministry of Education, Culture, Sports, Science, and Technology funderid: 16K19360; 16H05288 – fundername: Ministry of Health, Labor, and Welfare of Japan grantid: H26-Bsou-kanen-ippan-013 – fundername: Japan Agency for Medical Research and Development grantid: JP16fk0310512h0005 – fundername: The Japan Agency for Medical Research and Development grantid: JP16fk0310512h0005 – fundername: The Ministry of Education, Culture, Sports, Science, and Technology grantid: 16H05288 – fundername: The Ministry of Education, Culture, Sports, Science, and Technology grantid: 16K19360 – fundername: Japan Agency for Medical Research and Development grantid: 17fk0310101h0001 – fundername: Ministry of Education, Culture, Sports, Science, and Technology grantid: 16K19360 – fundername: The Japan Agency for Medical Research and Development grantid: 17fk0310101h0001 – fundername: Ministry of Education, Culture, Sports, Science, and Technology grantid: 16H05288 – fundername: The Japan Agency for Medical Research and Development grantid: JP18fk0310101h0002 |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR ACIJW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 AAMMB ADSXY AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4191-b264d1ad3c305a481e03128be498102e427fd5a1364ff3cc24921f3a683fd2ff3 |
IEDL.DBID | DR2 |
ISSN | 0270-9139 1527-3350 |
IngestDate | Fri Jul 11 15:10:42 EDT 2025 Wed Aug 13 08:09:05 EDT 2025 Thu Apr 03 06:59:35 EDT 2025 Thu Apr 24 22:51:53 EDT 2025 Tue Jul 01 05:13:31 EDT 2025 Wed Jan 22 16:44:11 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2018 by the American Association for the Study of Liver Diseases. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4191-b264d1ad3c305a481e03128be498102e427fd5a1364ff3cc24921f3a683fd2ff3 |
Notes | Supported by Health and Labour Sciences Research Grants (Research on Hepatitis) from the Ministry of Health, Labor, and Welfare of Japan (H26‐Bsou‐kanen‐ippan‐013), the Japan Agency for Medical Research and Development (17fk0310101h0001, JP16fk0310512h0005, JP18fk0310101h0002), and the Ministry of Education, Culture, Sports, Science, and Technology (16K19360 and 16H05288). SEE EDITORIAL ON PAGE 5 Potential conflict of interest: Dr. Mizokami consults for and is on the speakers’ bureau for Gilead. He is on the speakers’ bureau for Sysmex. Dr. Brenna C received grants from investigator‐sponsored research award. Dr. Tanaka advises, is on the speakers’ bureau of, and received grants from Chugai. He advises and is on the speakers’ bureau for Gilead. He is on the speakers’ bureau for and received grants from Bristol‐Myers Squibb and Fujirebio. He advises Janssen. He is on the speakers’ bureau for GlaxoSmithKline. He received grants from Toyama/Fujifilm. . ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 29893492 |
PQID | 2164426119 |
PQPubID | 996352 |
PageCount | 1111 |
ParticipantIDs | proquest_miscellaneous_2054924663 proquest_journals_2164426119 pubmed_primary_29893492 crossref_primary_10_1002_hep_30111 crossref_citationtrail_10_1002_hep_30111 wiley_primary_10_1002_hep_30111_HEP30111 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | January 2019 2019-01-00 20190101 |
PublicationDateYYYYMMDD | 2019-01-01 |
PublicationDate_xml | – month: 01 year: 2019 text: January 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2019 |
Publisher | Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wolters Kluwer Health, Inc |
References | 1991; 351 2004; 63 2010; 15 2004; 40 2013; 87 2009; 83 2000; 118 2015; 386 2011; 81 2015; 385 2008; 38 2013; 288 2004; 3 2011; 59 2008; 100 1994; 82 2016; 37 2009; 136 2016; 36 2012; 10 2013; 18 2005; 280 2016; 7 2007; 195 1999; 19 2010; 29 2006; 44 2015; 63 2009; 286 2014; 57 2011; 21 2009; 3 1998; 188 2001; 34 1993; 138 2008; 132 2014; 12 2014; 147 2009; 104 1990; 150 2011; 286 2003; 22 1992; 4 (hep30111-bib-0028-20250401) 2011; 286 (hep30111-bib-0016-20250401) 1999; 19 (hep30111-bib-0038-20250401) 1991; 351 (hep30111-bib-0014-20250401) 1993; 138 (hep30111-bib-0039-20250401) 1992; 4 (hep30111-bib-0009-20250401) 2008; 100 (hep30111-bib-0043-20250401) 2011; 21 (hep30111-bib-0019-20250401) 2009; 104 (hep30111-bib-0044-20250401) 2010; 29 (hep30111-bib-0008-20250401) 2000; 118 (hep30111-bib-0034-20250401) 2003; 22 (hep30111-bib-0013-20250401) 2015; 386 (hep30111-bib-0003-20250401) 2014; 57 (hep30111-bib-0029-20250401) 2004; 63 (hep30111-bib-0040-20250401) 2012; 10 (hep30111-bib-0007-20250401) 2001; 34 (hep30111-bib-0005-20250401) 2009; 286 (hep30111-bib-0002-20250401) 2010; 15 (hep30111-bib-0041-20250401) 2016; 37 (hep30111-bib-0024-20250401) 2009; 83 (hep30111-bib-0036-20250401) 2013; 18 (hep30111-bib-0001-20250401) 2015; 385 (hep30111-bib-0021-20250401) 2004; 40 (hep30111-bib-0012-20250401) 2006; 44 (hep30111-bib-0017-20250401) 2016; 36 (hep30111-bib-0031-20250401) 2000; 118 (hep30111-bib-0015-20250401) 1990; 150 (hep30111-bib-0030-20250401) 2014; 147 (hep30111-bib-0006-20250401) 2009; 3 (hep30111-bib-0032-20250401) 2011; 81 (hep30111-bib-0020-20250401) 2014; 12 (hep30111-bib-0027-20250401) 2013; 288 (hep30111-bib-0026-20250401) 2015; 63 (hep30111-bib-0004-20250401) 2007; 195 (hep30111-bib-0035-20250401) 2013; 87 (hep30111-bib-0022-20250401) 2005; 280 (hep30111-bib-0025-20250401) 2008; 38 (hep30111-bib-0018-20250401) 2007; 195 (hep30111-bib-0042-20250401) 2004; 3 (hep30111-bib-0045-20250401) 1998; 188 (hep30111-bib-0010-20250401) 2016; 7 (hep30111-bib-0011-20250401) 2009; 136 (hep30111-bib-0023-20250401) 2008; 132 (hep30111-bib-0033-20250401) 1994; 82 (hep30111-bib-0037-20250401) 2011; 59 30137676 - Hepatology. 2019 Jan;69(1):5-8 |
References_xml | – volume: 10 start-page: 1265 year: 2012 end-page: 1270 article-title: GAB2—a scaffolding protein in cancer publication-title: Mol Cancer Res – volume: 19 start-page: 271 year: 1999 end-page: 285 article-title: Epidemiology of primary liver cancer publication-title: Semin Liver Dis – volume: 12 start-page: 701 year: 2014 end-page: 706 article-title: Relationship between level of hepatitis B virus DNA and liver disease: a population‐based study of hepatitis B e antigen–negative persons with hepatitis B publication-title: Clin Gastroenterol Hepatol – volume: 81 start-page: 372 year: 2011 end-page: 380 article-title: Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma publication-title: Oncology – volume: 150 start-page: 1051 year: 1990 end-page: 1054 article-title: Hepatitis B–related sequelae. Prospective study in 1400 hepatitis B surface antigen‐positive Alaska native carriers publication-title: Arch Intern Med – volume: 15 start-page: 5 issue: Suppl. 4 year: 2010 end-page: 13 article-title: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective publication-title: Oncologist – volume: 286 start-page: 80 year: 2009 end-page: 88 article-title: Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma publication-title: Cancer Lett – volume: 38 start-page: 234 year: 2008 end-page: 243 article-title: Development and public release of a comprehensive hepatitis virus database publication-title: Hepatol Res – volume: 147 start-page: 577 year: 2014 end-page: 594 article-title: Roles for chemokines in liver disease publication-title: Gastroenterology – volume: 288 start-page: 31715 year: 2013 end-page: 31727 article-title: Interleukin‐1 and tumor necrosis factor‐α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation‐induced cytidine deaminase (AID) publication-title: J Biol Chem – volume: 351 start-page: 317 year: 1991 end-page: 320 article-title: HBx gene of hepatitis B virus induces liver cancer in transgenic mice publication-title: Nature – volume: 34 start-page: 590 year: 2001 end-page: 594 article-title: Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan publication-title: Hepatology – volume: 138 start-page: 544 year: 1993 end-page: 549 article-title: Seroprevalence of hepatitis B viral markers in 52,000 Alaska natives publication-title: Am J Epidemiol – volume: 21 start-page: 10 year: 2011 end-page: 20 article-title: Mitogen‐activated protein kinases in hepatocellular carcinoma development publication-title: Semin Cancer Biol – volume: 104 start-page: 363 year: 2009 end-page: 370 article-title: Chronic liver disease among Alaska‐native people, 2003‐2004 publication-title: Am J Gastroenterol – volume: 37 start-page: 11763 year: 2016 end-page: 11773 article-title: GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma publication-title: Tumor Biol – volume: 83 start-page: 10538 year: 2009 end-page: 10547 article-title: A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J publication-title: J Virol – volume: 188 start-page: 341 year: 1998 end-page: 350 article-title: Immune pathogenesis of hepatocellular carcinoma publication-title: JExp Med – volume: 7 start-page: 12525 year: 2016 end-page: 12536 article-title: Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV‐related hepatocellular carcinoma: a meta‐analysis publication-title: Oncotarget – volume: 57 start-page: 141 year: 2014 end-page: 150 article-title: Genotypes and genetic variability of hepatitis B virus publication-title: Intervirology – volume: 3 start-page: 334 year: 2009 end-page: 342 article-title: The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B publication-title: Hepatol Int – volume: 59 start-page: 114 year: 2011 end-page: 122 article-title: New perspectives on the evolutionary history of hepatitis B virus genotype F publication-title: Mol Phylogenet Evol – volume: 118 start-page: 1169 year: 2000 end-page: 1178 article-title: An oral endothelin‐A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis publication-title: Gastroenterology – volume: 40 start-page: 747 year: 2004 end-page: 755 article-title: A case–control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D publication-title: Hepatology – volume: 385 start-page: 117 year: 2015 end-page: 171 article-title: Global, regional, and national age‐sex specific all‐cause and cause‐specific mortality for 240 causes of death, 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013 publication-title: Lancet – volume: 280 start-page: 21713 year: 2005 end-page: 21719 article-title: Hepatitis B virus DNA‐negative dane particles lack core protein but contain a 22kDa precore protein without C‐terminal arginine‐rich domain publication-title: J Biol Chem – volume: 286 start-page: 27081 year: 2011 end-page: 27091 article-title: Characterization of oligomer formation of amyloid‐beta peptide using a split‐luciferase complementation assay publication-title: J Biol Chem – volume: 87 start-page: 8075 year: 2013 end-page: 8084 article-title: The L60V variation in hepatitis B virus core protein elicits new epitope‐specific cytotoxic T lymphocytes and enhances viral replication publication-title: J Virol – volume: 36 start-page: 1507 year: 2016 end-page: 1515 article-title: Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska native people publication-title: Liver Int – volume: 18 start-page: 459 year: 2013 end-page: 465 article-title: Distribution of HBV genotypes in Latin America publication-title: Antivir Ther – volume: 44 start-page: 915 year: 2006 end-page: 924 article-title: Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens publication-title: Hepatology – volume: 63 start-page: 1 year: 2004 end-page: 70 article-title: Duck hepatitis B virus: an invaluable model system for HBV infection publication-title: Adv Virus Res – volume: 195 start-page: 1 year: 2007 end-page: 4 article-title: Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes publication-title: J Infect Dis – volume: 386 start-page: 1546 year: 2015 end-page: 1555 article-title: Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 publication-title: Lancet – volume: 132 start-page: 174 year: 2008 end-page: 180 article-title: Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia publication-title: Virus Res – volume: 3 start-page: 1200 year: 2004 end-page: 1207 article-title: Cell cycle regulation and hepatocarcinogenesis publication-title: Cancer Biol Ther – volume: 63 start-page: 546 year: 2015 end-page: 553 article-title: Characterization of novel entecavir resistance mutations publication-title: J Hepatol – volume: 118 start-page: 554 year: 2000 end-page: 559 article-title: Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B publication-title: Gastroenterology – volume: 82 start-page: 571 year: 1994 end-page: 576 article-title: Proinflammatory cytokines and endotoxin stimulate ICAM‐1 gene expression and secretion by normal human hepatocytes publication-title: Immunology – volume: 4 start-page: 57 year: 1992 end-page: 61 article-title: The hepatitis B virus x protein transactivation of c‐fos and c‐myc proto‐oncogenes is mediated by multiple transcription factors publication-title: Arch Virol Suppl – volume: 29 start-page: 3908 year: 2010 end-page: 3920 article-title: Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma publication-title: Oncogene – volume: 136 start-page: 652 year: 2009 end-page: 662 article-title: Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase‐type plasminogen activator mouse with human hepatocytes publication-title: Gastroenterology – volume: 195 start-page: 5 year: 2007 end-page: 11 article-title: Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F publication-title: J Infect Dis – volume: 22 start-page: 3007 year: 2003 end-page: 3014 article-title: Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis publication-title: Oncogene – volume: 100 start-page: 1134 year: 2008 end-page: 1143 article-title: Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma publication-title: J Natl Cancer Inst – volume: 29 start-page: 3908 year: 2010 ident: hep30111-bib-0044-20250401 article-title: Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma publication-title: Oncogene doi: 10.1038/onc.2010.143 – volume: 3 start-page: 334 year: 2009 ident: hep30111-bib-0006-20250401 article-title: The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B publication-title: Hepatol Int doi: 10.1007/s12072-008-9112-z – volume: 34 start-page: 590 year: 2001 ident: hep30111-bib-0007-20250401 article-title: Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan publication-title: Hepatology doi: 10.1053/jhep.2001.27221 – volume: 37 start-page: 11763 year: 2016 ident: hep30111-bib-0041-20250401 article-title: GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma publication-title: Tumor Biol doi: 10.1007/s13277-016-5019-9 – volume: 38 start-page: 234 year: 2008 ident: hep30111-bib-0025-20250401 article-title: Development and public release of a comprehensive hepatitis virus database publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2007.00262.x – volume: 136 start-page: 652 year: 2009 ident: hep30111-bib-0011-20250401 article-title: Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase‐type plasminogen activator mouse with human hepatocytes publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.10.048 – volume: 286 start-page: 27081 year: 2011 ident: hep30111-bib-0028-20250401 article-title: Characterization of oligomer formation of amyloid‐beta peptide using a split‐luciferase complementation assay publication-title: J Biol Chem doi: 10.1074/jbc.M111.257378 – volume: 22 start-page: 3007 year: 2003 ident: hep30111-bib-0034-20250401 article-title: Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis publication-title: Oncogene doi: 10.1038/sj.onc.1206401 – volume: 195 start-page: 1 year: 2007 ident: hep30111-bib-0004-20250401 article-title: Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes publication-title: J Infect Dis doi: 10.1086/509898 – volume: 3 start-page: 1200 year: 2004 ident: hep30111-bib-0042-20250401 article-title: Cell cycle regulation and hepatocarcinogenesis publication-title: Cancer Biol Ther doi: 10.4161/cbt.3.12.1392 – volume: 286 start-page: 80 year: 2009 ident: hep30111-bib-0005-20250401 article-title: Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2009.07.013 – volume: 83 start-page: 10538 year: 2009 ident: hep30111-bib-0024-20250401 article-title: A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J publication-title: J Virol doi: 10.1128/JVI.00462-09 – volume: 59 start-page: 114 year: 2011 ident: hep30111-bib-0037-20250401 article-title: New perspectives on the evolutionary history of hepatitis B virus genotype F publication-title: Mol Phylogenet Evol doi: 10.1016/j.ympev.2011.01.010 – volume: 15 start-page: 5 issue: Suppl. 4 year: 2010 ident: hep30111-bib-0002-20250401 article-title: The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective publication-title: Oncologist – volume: 82 start-page: 571 year: 1994 ident: hep30111-bib-0033-20250401 article-title: Proinflammatory cytokines and endotoxin stimulate ICAM‐1 gene expression and secretion by normal human hepatocytes publication-title: Immunology – volume: 81 start-page: 372 year: 2011 ident: hep30111-bib-0032-20250401 article-title: Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma publication-title: Oncology doi: 10.1159/000335472 – volume: 195 start-page: 5 year: 2007 ident: hep30111-bib-0018-20250401 article-title: Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F publication-title: J Infect Dis doi: 10.1086/509894 – volume: 18 start-page: 459 year: 2013 ident: hep30111-bib-0036-20250401 article-title: Distribution of HBV genotypes in Latin America publication-title: Antivir Ther doi: 10.3851/IMP2599 – volume: 40 start-page: 747 year: 2004 ident: hep30111-bib-0021-20250401 article-title: A case–control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D publication-title: Hepatology doi: 10.1002/hep.20365 – volume: 10 start-page: 1265 year: 2012 ident: hep30111-bib-0040-20250401 article-title: GAB2—a scaffolding protein in cancer publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-12-0352 – volume: 63 start-page: 1 year: 2004 ident: hep30111-bib-0029-20250401 article-title: Duck hepatitis B virus: an invaluable model system for HBV infection publication-title: Adv Virus Res doi: 10.1016/S0065-3527(04)63001-6 – volume: 288 start-page: 31715 year: 2013 ident: hep30111-bib-0027-20250401 article-title: Interleukin‐1 and tumor necrosis factor‐α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation‐induced cytidine deaminase (AID) publication-title: J Biol Chem doi: 10.1074/jbc.M113.501122 – volume: 104 start-page: 363 year: 2009 ident: hep30111-bib-0019-20250401 article-title: Chronic liver disease among Alaska‐native people, 2003‐2004 publication-title: Am J Gastroenterol doi: 10.1038/ajg.2008.57 – volume: 351 start-page: 317 year: 1991 ident: hep30111-bib-0038-20250401 article-title: HBx gene of hepatitis B virus induces liver cancer in transgenic mice publication-title: Nature doi: 10.1038/351317a0 – volume: 63 start-page: 546 year: 2015 ident: hep30111-bib-0026-20250401 article-title: Characterization of novel entecavir resistance mutations publication-title: J Hepatol doi: 10.1016/j.jhep.2015.03.020 – volume: 385 start-page: 117 year: 2015 ident: hep30111-bib-0001-20250401 article-title: Global, regional, and national age‐sex specific all‐cause and cause‐specific mortality for 240 causes of death, 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013 publication-title: Lancet doi: 10.1016/S0140-6736(14)61682-2 – volume: 19 start-page: 271 year: 1999 ident: hep30111-bib-0016-20250401 article-title: Epidemiology of primary liver cancer publication-title: Semin Liver Dis doi: 10.1055/s-2007-1007117 – volume: 21 start-page: 10 year: 2011 ident: hep30111-bib-0043-20250401 article-title: Mitogen‐activated protein kinases in hepatocellular carcinoma development publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2010.10.011 – volume: 118 start-page: 554 year: 2000 ident: hep30111-bib-0008-20250401 article-title: Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B publication-title: Gastroenterology doi: 10.1016/S0016-5085(00)70261-7 – volume: 118 start-page: 1169 year: 2000 ident: hep30111-bib-0031-20250401 article-title: An oral endothelin‐A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis publication-title: Gastroenterology doi: 10.1016/S0016-5085(00)70370-2 – volume: 280 start-page: 21713 year: 2005 ident: hep30111-bib-0022-20250401 article-title: Hepatitis B virus DNA‐negative dane particles lack core protein but contain a 22kDa precore protein without C‐terminal arginine‐rich domain publication-title: J Biol Chem doi: 10.1074/jbc.M501564200 – volume: 57 start-page: 141 year: 2014 ident: hep30111-bib-0003-20250401 article-title: Genotypes and genetic variability of hepatitis B virus publication-title: Intervirology doi: 10.1159/000360947 – volume: 138 start-page: 544 year: 1993 ident: hep30111-bib-0014-20250401 article-title: Seroprevalence of hepatitis B viral markers in 52,000 Alaska natives publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116888 – volume: 36 start-page: 1507 year: 2016 ident: hep30111-bib-0017-20250401 article-title: Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska native people publication-title: Liver Int doi: 10.1111/liv.13129 – volume: 7 start-page: 12525 year: 2016 ident: hep30111-bib-0010-20250401 article-title: Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV‐related hepatocellular carcinoma: a meta‐analysis publication-title: Oncotarget doi: 10.18632/oncotarget.7123 – volume: 188 start-page: 341 year: 1998 ident: hep30111-bib-0045-20250401 article-title: Immune pathogenesis of hepatocellular carcinoma publication-title: JExp Med doi: 10.1084/jem.188.2.341 – volume: 386 start-page: 1546 year: 2015 ident: hep30111-bib-0013-20250401 article-title: Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 publication-title: Lancet doi: 10.1016/S0140-6736(15)61412-X – volume: 12 start-page: 701 year: 2014 ident: hep30111-bib-0020-20250401 article-title: Relationship between level of hepatitis B virus DNA and liver disease: a population‐based study of hepatitis B e antigen–negative persons with hepatitis B publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2013.09.005 – volume: 4 start-page: 57 year: 1992 ident: hep30111-bib-0039-20250401 article-title: The hepatitis B virus x protein transactivation of c‐fos and c‐myc proto‐oncogenes is mediated by multiple transcription factors publication-title: Arch Virol Suppl doi: 10.1007/978-3-7091-5633-9_12 – volume: 100 start-page: 1134 year: 2008 ident: hep30111-bib-0009-20250401 article-title: Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djn243 – volume: 44 start-page: 915 year: 2006 ident: hep30111-bib-0012-20250401 article-title: Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens publication-title: Hepatology doi: 10.1002/hep.21345 – volume: 147 start-page: 577 year: 2014 ident: hep30111-bib-0030-20250401 article-title: Roles for chemokines in liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.06.043 – volume: 150 start-page: 1051 year: 1990 ident: hep30111-bib-0015-20250401 article-title: Hepatitis B–related sequelae. Prospective study in 1400 hepatitis B surface antigen‐positive Alaska native carriers publication-title: Arch Intern Med doi: 10.1001/archinte.1990.00390170087019 – volume: 132 start-page: 174 year: 2008 ident: hep30111-bib-0023-20250401 article-title: Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia publication-title: Virus Res doi: 10.1016/j.virusres.2007.12.005 – volume: 87 start-page: 8075 year: 2013 ident: hep30111-bib-0035-20250401 article-title: The L60V variation in hepatitis B virus core protein elicits new epitope‐specific cytotoxic T lymphocytes and enhances viral replication publication-title: J Virol doi: 10.1128/JVI.00577-13 – reference: 30137676 - Hepatology. 2019 Jan;69(1):5-8 |
SSID | ssj0009428 |
Score | 2.435388 |
Snippet | Hepatitis B virus (HBV) genotype F1b infection is strongly associated with hepatocellular carcinoma (HCC) in young Alaskan Native (AN) people. However, the... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 19 |
SubjectTerms | Adolescent Adult Aged Alaska Bradykinin Carcinogenesis Carcinoma, Hepatocellular - complications Carcinoma, Hepatocellular - virology Cell proliferation Child Child, Preschool Chronic infection Core protein Dimerization DNA microarrays Fibrosis Follistatin Genotype Genotype & phenotype Genotypes Grb2 protein Hepatitis Hepatitis B Hepatitis B surface antigen Hepatitis B virus - classification Hepatitis B virus - genetics Hepatitis B, Chronic - complications Hepatocellular carcinoma Hepatocytes Hepatology Humans Indigenous Peoples Infant Infections Kinases Liver cancer Liver Neoplasms - complications Liver Neoplasms - virology Middle Aged Mutation Myc protein Protein kinase Proteins Young Adult |
Title | An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.30111 https://www.ncbi.nlm.nih.gov/pubmed/29893492 https://www.proquest.com/docview/2164426119 https://www.proquest.com/docview/2054924663 |
Volume | 69 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hDhWXlpY-FmjlVj30Etg43iVRT8uKZVUJhKpScagU-SlWtA7abC5I_PfO2EkofUiotygZy4nHY3_jmXwD8F7lI5UaR0UzrEwQEadJkcssMdyOuB5qrl3Itjgdz8_Fp4vRxRp87P6FifwQ_YEbWUZYr8nApar370hDLy067FQpHddfytUiQPT5jjqqEKGuKnpdQ4ouFx2r0JDv9y3v70V_AMz7eDVsOLMn8K171ZhncrXXrNSevvmNxfE_v2UTHrdAlE3izHkKa9Y_g0cnbah9C24nnv2iO3YYE7rYtFpadtLECH7NFp7NLWVlrxY1O2RfF8umZsfWV3S2y2apYtKbKFJRkICyXtmUChj56oek5hPE71fSs9NAQc7OQkr7czifHX2ZzpO2VkOiBbp8iUJgZVJpMo0LiBR5anG14LmyosgRw1jBD5wZSVSUcC7TmogKU5fJcZ45w_HWC1j3lbevgAmXHZh0LMdOovPqhEKXyEiJWELn1jo3gA-d1krdEplTPY3vZaRg5iUOZxmGcwDvetHryN7xN6HdTvVla8B1ydGNJO8yLQbwtn-MpkdDJb2tGpQZEr2dQMw2gJdxyvS9ELE9ET_iywbF_7v7cn50Fi62Hy66AxsI3Ip4FLQL66tlY18jOFqpN8EKfgIZ_Ald |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3o-FAgZx4JJ27XjTROKyXboE6K4q1KJeqshxbLEqOGh3c0HivzNjJynlISFuUTKWE9tjf_PINwAvynRU8spS0QyjIkTEPMpSFUeVMCOhh1po67Mt5kl-LN-djE424FX3L0zgh-gdbqQZfr8mBSeH9M45a-gngxY7lUq_BJepojcx57_-cE4elUlfWRXtriHFl7OOV2godvqmF0-j3yDmRcTqj5zpDTjtXjZkmpxtN-tyW3_7hcfxf7_mJlxvsSgbh8VzCzaMuw1XZm20_Q58Hzv20_SxvZDTxSb10rBZE4L4K7ZwLDeUmL1erNge-7hYNiv2xria3LtsykumXBVEaooTUOIrm1ANI1d_UdR8jBD-TDk29yzk7NBntd-F4-n-0SSP2nINkZZo9UUlYquKqyrWuIcomXKDG4ZISyOzFGGMkWLXViPF40RaG2tNXIXcxipJY1sJvHUPNl3tzANg0sa7FU9UYhXar1aWaBVVSiGc0Kkx1g7gZTdthW65zKmkxucisDCLAoez8MM5gOe96NdA4PEnoa1u7otWh1eFQEuSDEyeDeBZ_xi1j4ZKOVM3KDMkhjuJsG0A98Oa6XshbnvifsSX9TP_9-6LfP_QXzz8d9GncDU_mh0UB2_n7x_BNcRxWfAMbcHmetmYx4iV1uUTrxI_AKfjDXk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVceD8WChjEgUvaOPGmiThtt12WR1crRFEPlSLHD7EqONXu5oLEf2fGTlLKQ0LcomQsJx6P_Y1n8g3AiyofVlxbKpphZISImEdFLtNIJ2aYqFglyvpsi1k2PRZvT4YnG_Cq-xcm8EP0B25kGX69JgM_13b3gjT0s0GHnSqlX4GrIosLqttw8OGCO6oQvrAqul0xhZeLjlYoTnb7ppc3o98Q5mXA6necyQ047d41JJqc7TTrakd9-4XG8T8_5iZcb5EoG4Wpcws2jLsNW0dtrP0OfB859pPy2H7I6GLjemnYURNC-Cu2cGxqKC17vVixffZpsWxW7LVxNR3usgmvmHQ6iNQUJaC0VzamCkau_iqp-QgB_Jl0bOY5yNnc57TfhePJ4cfxNGqLNURKoM8XVYisNJc6VbiCSJFzg8tFkldGFDmCGCOSPauHkqeZsDZVipgKuU1llqdWJ3jrHmy62pkHwIRN9zTPZGYleq9WVOgTaSkRTKjcGGsH8LLTWqlaJnMqqPGlDBzMSYnDWfrhHMDzXvQ80Hf8SWi7U33ZWvCqTNCPJPeSFwN41j9G26Ohks7UDcrExG8nELQN4H6YMn0vxGxPzI_4sl7xf---nB7O_cXDfxd9Clvzg0n5_s3s3SO4hiCuCMdC27C5XjbmMQKldfXEG8QPdiMMKA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Association+Between+Core+Mutations+in+Hepatitis+B+Virus+Genotype+F1b+and+Hepatocellular+Carcinoma+in+Alaskan+Native+People&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Hayashi%2C+Sanae&rft.au=Khan%2C+Anis&rft.au=Simons%2C+Brenna+C&rft.au=Homan%2C+Chriss&rft.date=2019-01-01&rft.eissn=1527-3350&rft.volume=69&rft.issue=1&rft.spage=19&rft_id=info:doi/10.1002%2Fhep.30111&rft_id=info%3Apmid%2F29893492&rft.externalDocID=29893492 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |